Algert Global’s Altimmune ALT Stock Holding History

Algert Global’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-18,560	Closed	-$305K	–	1130
2022 Q4	$305K	Buy	18,560 +5,280	+40%	+$59.3K	0.02%	930
2022 Q3	$170K	Buy	+13,280	New	+$196K	0.01%	1056

Other funds holding ALT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Algert Global's ALT Position: Q1 2023 in Review

Algert Global sold out of Altimmune (ALT) in Q1 2023, closing a stake of 18,560 shares — an estimated $305K sold.

Algert Global first reported a position in ALT in Q3 2022 and held it in 2 quarters. The position peaked at $305K in Q4 2022. 132 funds tracked by Wall St. Rank hold ALT as of Q1 2023.

Algert Global reported no remaining Altimmune position as of Q1 2023 after selling out during the quarter.
Algert Global sold 18,560 Altimmune shares in Q1 2023, an estimated $305K.
Algert Global first reported a position in Altimmune in Q3 2022 and held it in 2 quarters.
Algert Global's Altimmune position peaked at $305K in Q4 2022.
132 funds tracked by Wall St. Rank held Altimmune as of Q1 2023.

Based on Algert Global's 13F filing for Q1 2023, filed 12 May 2023.